Skip to main content
OpenTrials

Clinical trial condition

Female Urogenital Diseases

Explore clinical trials studying Female Urogenital Diseases. Study availability and eligibility vary by location and protocol.

21,753 public trials 3,740 recruiting studies
Refine in advanced search Browse all conditions

Female Urogenital Diseases trial results

Terminated

Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod

NCT00799110

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Brigham & Women's Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View Trial Details
Terminated

Study to Evaluate the Safety and Efficacy of GSK1278863 in Recombinant Human Erythropoietin (rhEPO) Hyporesponsive Hemodialysis-dependent Chronic Kidney Disease Subjects With Anemia

NCT02075463

Conditions
Anaemia, Anemia, Chronic Disease, +13 more
Locations
  • GSK Investigational Site Azusa, California, United States
  • GSK Investigational Site Glendale, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Simi Valley, California, United States
View Trial Details
Terminated

Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatments and Combinations in Patients With Urothelial Carcinoma (MORPHEUS-UC)

NCT03869190

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +14 more
Locations
  • UCLA Department of Medicine Los Angeles, California, United States
  • UCSF Comprehensive Cancer Ctr San Francisco, California, United States
  • Stanford Cancer Center Stanford, California, United States
  • University of Kentucky Chandler Medical Center Lexington, Kentucky, United States
View all 33 locations
View Trial Details
Suspended

Testing the Combination of ZEN003694 and Nivolumab With or Without Ipilimumab in Solid Tumors

NCT04840589

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +20 more
Locations
  • National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • Mount Sinai Hospital New York, United States
  • Montefiore Medical Center-Einstein Campus The Bronx, New York, United States
View Trial Details

Related conditions